APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flutamide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Flutamide Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchFlutamide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Flutamide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Flutamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flutamide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Flutamide Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Flutamide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Flutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Flutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Flutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Flutamide include Tasly Diyi Pharma, Forward, SANDOZ, Merck, TEVA Pharma, Florencia Healthcare, Cipla LifeScience and Actiza Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flutamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flutamide, also provides the sales of main regions and countries. Of the upcoming market potential for Flutamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flutamide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flutamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flutamide sales, projected growth trends, production technology, application and end-user industry.

Flutamide Segment by Company

Tasly Diyi Pharma

Forward

SANDOZ

Merck

TEVA Pharma

Florencia Healthcare

Cipla LifeScience

Actiza Pharma

Flutamide Segment by Type

Flutamide Tablets

Flutamide Capsule

Others

Flutamide Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Flutamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flutamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flutamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flutamide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flutamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Flutamide Tablets Major Manufacturers Table 3. Flutamide Capsule Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Flutamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Flutamide Industry Trends Table 10. Flutamide Industry Drivers Table 11. Flutamide Industry Opportunities and Challenges Table 12. Flutamide Industry Restraints Table 13. Global Flutamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Flutamide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Flutamide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Flutamide Revenue Market Share by Region (2021-2026) Table 17. Global Flutamide Revenue Market Share by Region (2027-2032) Table 18. Global Flutamide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 19. Global Flutamide Sales by Region (2021-2026) & (kg) Table 20. Global Flutamide Sales by Region (2027-2032) & (kg) Table 21. Global Flutamide Sales Market Share by Region (2021-2026) Table 22. Global Flutamide Sales Market Share by Region (2027-2032) Table 23. Global Flutamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Flutamide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Flutamide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Flutamide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Flutamide Sales Price (US$/kg) of Manufacturers (2021-2026) Table 28. Global Flutamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Flutamide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Flutamide Manufacturers, Product Type & Application Table 31. Global Flutamide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Flutamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Flutamide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Flutamide Revenue Market Share by Type (2021-2026) Table 38. Global Flutamide Revenue Market Share by Type (2027-2032) Table 39. Global Flutamide Sales by Type 2021 VS 2025 VS 2032 (kg) Table 40. Global Flutamide Sales by Type (2021-2026) & (kg) Table 41. Global Flutamide Sales by Type (2027-2032) & (kg) Table 42. Global Flutamide Sales Market Share by Type (2021-2026) Table 43. Global Flutamide Sales Market Share by Type (2027-2032) Table 44. Global Flutamide Price by Type (2021-2026) & (US$/kg) Table 45. Global Flutamide Price by Type (2027-2032) & (US$/kg) Table 46. Global Flutamide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Flutamide Revenue Market Share by Application (2021-2026) Table 50. Global Flutamide Revenue Market Share by Application (2027-2032) Table 51. Global Flutamide Sales by Application 2021 VS 2025 VS 2032 (kg) Table 52. Global Flutamide Sales by Application (2021-2026) & (kg) Table 53. Global Flutamide Sales by Application (2027-2032) & (kg) Table 54. Global Flutamide Sales Market Share by Application (2021-2026) Table 55. Global Flutamide Sales Market Share by Application (2027-2032) Table 56. Global Flutamide Price by Application (2021-2026) & (US$/kg) Table 57. Global Flutamide Price by Application (2027-2032) & (US$/kg) Table 58. Tasly Diyi Pharma Company Information Table 59. Tasly Diyi Pharma Business Overview Table 60. Tasly Diyi Pharma Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. Tasly Diyi Pharma Flutamide Product Portfolio Table 62. Tasly Diyi Pharma Recent Development Table 63. Forward Company Information Table 64. Forward Business Overview Table 65. Forward Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Forward Flutamide Product Portfolio Table 67. Forward Recent Development Table 68. SANDOZ Company Information Table 69. SANDOZ Business Overview Table 70. SANDOZ Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. SANDOZ Flutamide Product Portfolio Table 72. SANDOZ Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Merck Flutamide Product Portfolio Table 77. Merck Recent Development Table 78. TEVA Pharma Company Information Table 79. TEVA Pharma Business Overview Table 80. TEVA Pharma Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. TEVA Pharma Flutamide Product Portfolio Table 82. TEVA Pharma Recent Development Table 83. Florencia Healthcare Company Information Table 84. Florencia Healthcare Business Overview Table 85. Florencia Healthcare Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Florencia Healthcare Flutamide Product Portfolio Table 87. Florencia Healthcare Recent Development Table 88. Cipla LifeScience Company Information Table 89. Cipla LifeScience Business Overview Table 90. Cipla LifeScience Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Cipla LifeScience Flutamide Product Portfolio Table 92. Cipla LifeScience Recent Development Table 93. Actiza Pharma Company Information Table 94. Actiza Pharma Business Overview Table 95. Actiza Pharma Flutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Actiza Pharma Flutamide Product Portfolio Table 97. Actiza Pharma Recent Development Table 98. North America Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Flutamide Sales by Type (2021-2026) & (kg) Table 101. North America Flutamide Sales by Type (2027-2032) & (kg) Table 102. North America Flutamide Sales Price by Type (2021-2026) & (US$/kg) Table 103. North America Flutamide Sales Price by Type (2027-2032) & (US$/kg) Table 104. North America Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Flutamide Sales by Application (2021-2026) & (kg) Table 107. North America Flutamide Sales by Application (2027-2032) & (kg) Table 108. North America Flutamide Sales Price by Application (2021-2026) & (US$/kg) Table 109. North America Flutamide Sales Price by Application (2027-2032) & (US$/kg) Table 110. North America Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Flutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Flutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Flutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 114. North America Flutamide Sales by Country (2021-2026) & (kg) Table 115. North America Flutamide Sales by Country (2027-2032) & (kg) Table 116. North America Flutamide Sales Price by Country (2021-2026) & (US$/kg) Table 117. North America Flutamide Sales Price by Country (2027-2032) & (US$/kg) Table 118. United States Flutamide Revenue (2021-2032) & (US$ Million) Table 119. Canada Flutamide Revenue (2021-2032) & (US$ Million) Table 120. Mexico Flutamide Revenue (2021-2032) & (US$ Million) Table 121. Europe Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Flutamide Sales by Type (2021-2026) & (kg) Table 124. Europe Flutamide Sales by Type (2027-2032) & (kg) Table 125. Europe Flutamide Sales Price by Type (2021-2026) & (US$/kg) Table 126. Europe Flutamide Sales Price by Type (2027-2032) & (US$/kg) Table 127. Europe Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Flutamide Sales by Application (2021-2026) & (kg) Table 130. Europe Flutamide Sales by Application (2027-2032) & (kg) Table 131. Europe Flutamide Sales Price by Application (2021-2026) & (US$/kg) Table 132. Europe Flutamide Sales Price by Application (2027-2032) & (US$/kg) Table 133. Europe Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Flutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Flutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Flutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 137. Europe Flutamide Sales by Country (2021-2026) & (kg) Table 138. Europe Flutamide Sales by Country (2027-2032) & (kg) Table 139. Europe Flutamide Sales Price by Country (2021-2026) & (US$/kg) Table 140. Europe Flutamide Sales Price by Country (2027-2032) & (US$/kg) Table 141. Germany Flutamide Revenue (2021-2032) & (US$ Million) Table 142. France Flutamide Revenue (2021-2032) & (US$ Million) Table 143. U.K. Flutamide Revenue (2021-2032) & (US$ Million) Table 144. Italy Flutamide Revenue (2021-2032) & (US$ Million) Table 145. Russia Flutamide Revenue (2021-2032) & (US$ Million) Table 146. Spain Flutamide Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Flutamide Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Flutamide Revenue (2021-2032) & (US$ Million) Table 149. Sweden Flutamide Revenue (2021-2032) & (US$ Million) Table 150. Poland Flutamide Revenue (2021-2032) & (US$ Million) Table 151. China Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 152. China Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 153. China Flutamide Sales by Type (2021-2026) & (kg) Table 154. China Flutamide Sales by Type (2027-2032) & (kg) Table 155. China Flutamide Sales Price by Type (2021-2026) & (US$/kg) Table 156. China Flutamide Sales Price by Type (2027-2032) & (US$/kg) Table 157. China Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 158. China Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 159. China Flutamide Sales by Application (2021-2026) & (kg) Table 160. China Flutamide Sales by Application (2027-2032) & (kg) Table 161. China Flutamide Sales Price by Application (2021-2026) & (US$/kg) Table 162. China Flutamide Sales Price by Application (2027-2032) & (US$/kg) Table 163. Asia Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Flutamide Sales by Type (2021-2026) & (kg) Table 166. Asia Flutamide Sales by Type (2027-2032) & (kg) Table 167. Asia Flutamide Sales Price by Type (2021-2026) & (US$/kg) Table 168. Asia Flutamide Sales Price by Type (2027-2032) & (US$/kg) Table 169. Asia Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Flutamide Sales by Application (2021-2026) & (kg) Table 172. Asia Flutamide Sales by Application (2027-2032) & (kg) Table 173. Asia Flutamide Sales Price by Application (2021-2026) & (US$/kg) Table 174. Asia Flutamide Sales Price by Application (2027-2032) & (US$/kg) Table 175. Asia Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Flutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Flutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Flutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 179. Asia Flutamide Sales by Country (2021-2026) & (kg) Table 180. Asia Flutamide Sales by Country (2027-2032) & (kg) Table 181. Asia Flutamide Sales Price by Country (2021-2026) & (US$/kg) Table 182. Asia Flutamide Sales Price by Country (2027-2032) & (US$/kg) Table 183. Japan Flutamide Revenue (2021-2032) & (US$ Million) Table 184. South Korea Flutamide Revenue (2021-2032) & (US$ Million) Table 185. India Flutamide Revenue (2021-2032) & (US$ Million) Table 186. Australia Flutamide Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Flutamide Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Flutamide Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Flutamide Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Flutamide Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Flutamide Sales by Type (2021-2026) & (kg) Table 192. SAMEA Flutamide Sales by Type (2027-2032) & (kg) Table 193. SAMEA Flutamide Sales Price by Type (2021-2026) & (US$/kg) Table 194. SAMEA Flutamide Sales Price by Type (2027-2032) & (US$/kg) Table 195. SAMEA Flutamide Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Flutamide Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Flutamide Sales by Application (2021-2026) & (kg) Table 198. SAMEA Flutamide Sales by Application (2027-2032) & (kg) Table 199. SAMEA Flutamide Sales Price by Application (2021-2026) & (US$/kg) Table 200. SAMEA Flutamide Sales Price by Application (2027-2032) & (US$/kg) Table 201. SAMEA Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Flutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Flutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Flutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 205. SAMEA Flutamide Sales by Country (2021-2026) & (kg) Table 206. SAMEA Flutamide Sales by Country (2027-2032) & (kg) Table 207. SAMEA Flutamide Sales Price by Country (2021-2026) & (US$/kg) Table 208. SAMEA Flutamide Sales Price by Country (2027-2032) & (US$/kg) Table 209. Brazil Flutamide Revenue (2021-2032) & (US$ Million) Table 210. Argentina Flutamide Revenue (2021-2032) & (US$ Million) Table 211. Chile Flutamide Revenue (2021-2032) & (US$ Million) Table 212. Colombia Flutamide Revenue (2021-2032) & (US$ Million) Table 213. Peru Flutamide Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Flutamide Revenue (2021-2032) & (US$ Million) Table 215. Israel Flutamide Revenue (2021-2032) & (US$ Million) Table 216. UAE Flutamide Revenue (2021-2032) & (US$ Million) Table 217. Turkey Flutamide Revenue (2021-2032) & (US$ Million) Table 218. Iran Flutamide Revenue (2021-2032) & (US$ Million) Table 219. Egypt Flutamide Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Flutamide Distributors List Table 223. Flutamide Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Flutamide Image Figure 2. Global Flutamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flutamide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Flutamide Tablets Image Figure 5. Flutamide Capsule Image Figure 6. Others Image Figure 7. Global Flutamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Flutamide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Flutamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Flutamide Revenue (2021-2032) & (US$ Million) Figure 14. Global Flutamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Flutamide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Flutamide Revenue Market Share by Region (2021-2032) Figure 17. Global Flutamide Sales (2021-2032) & (kg) Figure 18. Global Flutamide Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 19. Global Flutamide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Flutamide Sales YoY (2021-2032) & (kg) Figure 21. Europe Flutamide Sales YoY (2021-2032) & (kg) Figure 22. China Flutamide Sales YoY (2021-2032) & (kg) Figure 23. Asia (Excluding China) Flutamide Sales YoY (2021-2032) & (kg) Figure 24. South America, Middle East and Africa Flutamide Sales YoY (2021-2032) & (kg) Figure 25. Global Flutamide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Flutamide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Flutamide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Flutamide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Flutamide Revenue Market Share by Type (2021-2032) Figure 31. Global Flutamide Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 32. Global Flutamide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Flutamide Sales Market Share by Type (2021-2032) Figure 34. Global Flutamide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Flutamide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Flutamide Revenue Market Share by Application (2021-2032) Figure 37. Global Flutamide Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 38. Global Flutamide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Flutamide Sales Market Share by Application (2021-2032) Figure 40. North America Flutamide Revenue Share by Type (2021-2032) Figure 41. North America Flutamide Sales Share by Type (2021-2032) Figure 42. North America Flutamide Revenue Share by Application (2021-2032) Figure 43. North America Flutamide Sales Share by Application (2021-2032) Figure 44. North America Flutamide Revenue Share by Country (2021-2032) Figure 45. North America Flutamide Sales Share by Country (2021-2032) Figure 46. Europe Flutamide Revenue Share by Type (2021-2032) Figure 47. Europe Flutamide Sales Share by Type (2021-2032) Figure 48. Europe Flutamide Revenue Share by Application (2021-2032) Figure 49. Europe Flutamide Sales Share by Application (2021-2032) Figure 50. Europe Flutamide Revenue Share by Country (2021-2032) Figure 51. Europe Flutamide Sales Share by Country (2021-2032) Figure 52. China Flutamide Revenue Share by Type (2021-2032) Figure 53. China Flutamide Sales Share by Type (2021-2032) Figure 54. China Flutamide Revenue Share by Application (2021-2032) Figure 55. China Flutamide Sales Share by Application (2021-2032) Figure 56. Asia Flutamide Revenue Share by Type (2021-2032) Figure 57. Asia Flutamide Sales Share by Type (2021-2032) Figure 58. Asia Flutamide Revenue Share by Application (2021-2032) Figure 59. Asia Flutamide Sales Share by Application (2021-2032) Figure 60. Asia Flutamide Revenue Share by Country (2021-2032) Figure 61. Asia Flutamide Sales Share by Country (2021-2032) Figure 62. SAMEA Flutamide Revenue Share by Type (2021-2032) Figure 63. SAMEA Flutamide Sales Share by Type (2021-2032) Figure 64. SAMEA Flutamide Revenue Share by Application (2021-2032) Figure 65. SAMEA Flutamide Sales Share by Application (2021-2032) Figure 66. SAMEA Flutamide Revenue Share by Country (2021-2032) Figure 67. SAMEA Flutamide Sales Share by Country (2021-2032) Figure 68. Flutamide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Flutamide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Flutamide Tablets
  • Flutamide Capsule
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Tasly Diyi Pharma
  • Forward
  • SANDOZ
  • Merck
  • TEVA Pharma
  • Florencia Healthcare
  • Cipla LifeScience
  • Actiza Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flutamide Market by Type
  3. 1.2.1 Global Flutamide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Flutamide Tablets
  5. 1.2.3 Flutamide Capsule
  6. 1.2.4 Others
  7. 1.3 Flutamide Market by Application
  8. 1.3.1 Global Flutamide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Flutamide Market Dynamics
  1. 2.1 Flutamide Industry Trends
  2. 2.2 Flutamide Industry Drivers
  3. 2.3 Flutamide Industry Opportunities and Challenges
  4. 2.4 Flutamide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flutamide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flutamide Revenue by Region
  3. 3.2.1 Global Flutamide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flutamide Revenue by Region (2021-2026)
  5. 3.2.3 Global Flutamide Revenue by Region (2027-2032)
  6. 3.2.4 Global Flutamide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flutamide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flutamide Sales by Region
  9. 3.4.1 Global Flutamide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flutamide Sales by Region (2021-2026)
  11. 3.4.3 Global Flutamide Sales by Region (2027-2032)
  12. 3.4.4 Global Flutamide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flutamide Revenue by Manufacturers
  2. 4.1.1 Global Flutamide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flutamide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flutamide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flutamide Sales by Manufacturers
  6. 4.2.1 Global Flutamide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flutamide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flutamide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flutamide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flutamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flutamide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flutamide Manufacturers, Product Type & Application
  13. 4.7 Global Flutamide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flutamide Market CR5 and HHI
  16. 4.8.2 2025 Flutamide Tier 1, Tier 2, and Tier 3
5 Flutamide Market by Type
  1. 5.1 Global Flutamide Revenue by Type
  2. 5.1.1 Global Flutamide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flutamide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flutamide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flutamide Sales by Type
  6. 5.2.1 Global Flutamide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flutamide Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Flutamide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flutamide Price by Type
6 Flutamide Market by Application
  1. 6.1 Global Flutamide Revenue by Application
  2. 6.1.1 Global Flutamide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flutamide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flutamide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flutamide Sales by Application
  6. 6.2.1 Global Flutamide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flutamide Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Flutamide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flutamide Price by Application
7 Company Profiles
  1. 7.1 Tasly Diyi Pharma
  2. 7.1.1 Tasly Diyi Pharma Company Information
  3. 7.1.2 Tasly Diyi Pharma Business Overview
  4. 7.1.3 Tasly Diyi Pharma Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Tasly Diyi Pharma Flutamide Product Portfolio
  6. 7.1.5 Tasly Diyi Pharma Recent Developments
  7. 7.2 Forward
  8. 7.2.1 Forward Company Information
  9. 7.2.2 Forward Business Overview
  10. 7.2.3 Forward Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Forward Flutamide Product Portfolio
  12. 7.2.5 Forward Recent Developments
  13. 7.3 SANDOZ
  14. 7.3.1 SANDOZ Company Information
  15. 7.3.2 SANDOZ Business Overview
  16. 7.3.3 SANDOZ Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 SANDOZ Flutamide Product Portfolio
  18. 7.3.5 SANDOZ Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Flutamide Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 TEVA Pharma
  26. 7.5.1 TEVA Pharma Company Information
  27. 7.5.2 TEVA Pharma Business Overview
  28. 7.5.3 TEVA Pharma Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TEVA Pharma Flutamide Product Portfolio
  30. 7.5.5 TEVA Pharma Recent Developments
  31. 7.6 Florencia Healthcare
  32. 7.6.1 Florencia Healthcare Company Information
  33. 7.6.2 Florencia Healthcare Business Overview
  34. 7.6.3 Florencia Healthcare Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Florencia Healthcare Flutamide Product Portfolio
  36. 7.6.5 Florencia Healthcare Recent Developments
  37. 7.7 Cipla LifeScience
  38. 7.7.1 Cipla LifeScience Company Information
  39. 7.7.2 Cipla LifeScience Business Overview
  40. 7.7.3 Cipla LifeScience Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cipla LifeScience Flutamide Product Portfolio
  42. 7.7.5 Cipla LifeScience Recent Developments
  43. 7.8 Actiza Pharma
  44. 7.8.1 Actiza Pharma Company Information
  45. 7.8.2 Actiza Pharma Business Overview
  46. 7.8.3 Actiza Pharma Flutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Actiza Pharma Flutamide Product Portfolio
  48. 7.8.5 Actiza Pharma Recent Developments
8 North America
  1. 8.1 North America Flutamide Market Size by Type
  2. 8.1.1 North America Flutamide Revenue by Type (2021-2032)
  3. 8.1.2 North America Flutamide Sales by Type (2021-2032)
  4. 8.1.3 North America Flutamide Price by Type (2021-2032)
  5. 8.2 North America Flutamide Market Size by Application
  6. 8.2.1 North America Flutamide Revenue by Application (2021-2032)
  7. 8.2.2 North America Flutamide Sales by Application (2021-2032)
  8. 8.2.3 North America Flutamide Price by Application (2021-2032)
  9. 8.3 North America Flutamide Market Size by Country
  10. 8.3.1 North America Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flutamide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Flutamide Market Size by Type
  2. 9.1.1 Europe Flutamide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flutamide Sales by Type (2021-2032)
  4. 9.1.3 Europe Flutamide Price by Type (2021-2032)
  5. 9.2 Europe Flutamide Market Size by Application
  6. 9.2.1 Europe Flutamide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flutamide Sales by Application (2021-2032)
  8. 9.2.3 Europe Flutamide Price by Application (2021-2032)
  9. 9.3 Europe Flutamide Market Size by Country
  10. 9.3.1 Europe Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flutamide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Flutamide Market Size by Type
  2. 10.1.1 China Flutamide Revenue by Type (2021-2032)
  3. 10.1.2 China Flutamide Sales by Type (2021-2032)
  4. 10.1.3 China Flutamide Price by Type (2021-2032)
  5. 10.2 China Flutamide Market Size by Application
  6. 10.2.1 China Flutamide Revenue by Application (2021-2032)
  7. 10.2.2 China Flutamide Sales by Application (2021-2032)
  8. 10.2.3 China Flutamide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flutamide Market Size by Type
  2. 11.1.1 Asia Flutamide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flutamide Sales by Type (2021-2032)
  4. 11.1.3 Asia Flutamide Price by Type (2021-2032)
  5. 11.2 Asia Flutamide Market Size by Application
  6. 11.2.1 Asia Flutamide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flutamide Sales by Application (2021-2032)
  8. 11.2.3 Asia Flutamide Price by Application (2021-2032)
  9. 11.3 Asia Flutamide Market Size by Country
  10. 11.3.1 Asia Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flutamide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flutamide Market Size by Type
  2. 12.1.1 SAMEA Flutamide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flutamide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flutamide Price by Type (2021-2032)
  5. 12.2 SAMEA Flutamide Market Size by Application
  6. 12.2.1 SAMEA Flutamide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flutamide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flutamide Price by Application (2021-2032)
  9. 12.3 SAMEA Flutamide Market Size by Country
  10. 12.3.1 SAMEA Flutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flutamide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flutamide Value Chain Analysis
  2. 13.1.1 Flutamide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flutamide Production Mode & Process
  6. 13.2 Flutamide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flutamide Distributors
  9. 13.2.3 Flutamide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst